In addition to the successful use of preventative vaccines used in the defense against cancer-causing infectious diseases, including hepatitis B virus and human papillomavirus, the knowledge that patients can harbor CD8+ and CD4+ T cells capable of recognizing tumor expressed antigens hinted at the possibility of developing cancer vaccines [5, 7]. The gene discussed is CD8A; the disease is cancer.